Skip to main content
TipRanks
Go Ultimate75% OFF

Bicara Therapeutics Inc. (BCAX) Income Statement

93 Followers

Bicara Therapeutics Inc. Income Statement

Last quarter (Q3 2026), Bicara Therapeutics Inc.'s total revenue was $0.00. In Q3, Bicara Therapeutics Inc.'s net income was $-71.25M. See Bicara Therapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22
$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ 0.00
$ 155.60M$ 82.39M$ 39.89M$ 37.66M
Depreciation and Amortization$ 105.00K$ 56.00K$ 19.00K$ 10.00K
$ -137.63M$ -67.75M$ -51.96M$ -37.72M
$ -155.60M$ -82.39M$ -39.89M$ -37.66M
$ 17.87M$ 14.58M$ -12.09M$ -188.00K
$ -137.73M$ -67.81M$ -51.98M$ -37.84M
$ -137.95M$ -68.00M$ -51.98M$ -37.84M
Per Share Metrics
Basic EPS$ -2.52$ -1.25$ -1.00$ -0.73
Diluted EPS$ -2.52$ -1.25$ -1.00$ -0.73
Weighted Average Shares Outstanding54.68M54.42M51.76M51.76M
Weighted Average Shares Outstanding (Diluted)54.68M54.42M51.76M51.76M

Currency in USD

Bicara Therapeutics Inc. Earnings and Revenue History

-150M-100M-50M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2022202320242025RevenueEarningsProfit Margin